MAPT and tauopathy: Due to apparent pattern differences of tauopathies between mouse and human, Detrez et al. proposed a controlled model by inoculating pathogenic tau fibrils to specific brain regions of tauopathy mouse model (Figure 3D) 78, providing us a novel strategy for volumetric optical clearing imaging of tau pathology in whole mouse brain.